drugset / Trial / NCT05414266

Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata

NCT05414266 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and tolerability of squaric acid dibutylester (SADBE) in children and adolescents with alopecia areata (AA) and to evaluate effect of squaric acid dibutyl ester on patient-centered outcomes and payer relevant measures to assess treatment benefit from the patient perspective and to demonstrate value

Timeline

Start
2022-08-15
Primary completion
2023-06-01
Completion
2024-05-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Squaric Acid Dibutyl Ester Small molecule 5 % Topical

Indications